Suzuken Acquires medimo, Developer of Medical Document Creation System – Kotora

The news of Suzuken making medimo, a developer of medical document creation systems, a subsidiary suggests a new phase in promoting DX within the healthcare industry.The fact that a major pharmaceutical wholesaler is not only involved in logistics and information provision but also in improving the efficiency of document creation, a core operation for medical institutions, is evidence of the expanding scope of support for medical institution management.

In the context of medical M&A and business succession, this move holds the potential to bring about significant changes in the evaluation criteria for medical institutions.potential to bring about significant changes in the evaluation criteria for medical institutionsIt holds inherent potential. For business owners grappling with succession challenges, the focus isn't solely on patient volume or facility assets,"how efficiently operations are conducted in a digitized environment"potential to bring about significant changes in the evaluation criteria for medical institutions

Executives of medical institutions should recognize that promoting DX in their own facilities is not merely a cost, but an "investment" for future business succession."investment" for future business successionThe introduction of efficient systems will enhance operational transparency, facilitate the handover process, and ultimately result in a more attractive M&A deal.Before considering closure, it is essential to explore the possibility of value enhancement through digitalization and subsequent succession.